Breast Cancer Diagnostics Market Size & Share Report, 2032

Breast Cancer Diagnostics Market – By Product (Instruments, Kits & Consumables), Test Type (Imaging, Biopsy, Genomic Test, Blood Test), Cancer Type (Ductal Carcinoma in Situ, Invasive Ductal Carcinoma), Application, End-use - Global Forecast 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of breast cancer globally

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in breast cancer diagnostics

3.2.1.3&nbsp;&nbsp;&nbsp; Rising government initiatives and awareness programs

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of diagnostic tests

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Core technologies

3.5.2&nbsp;&nbsp;&nbsp; Adjacent technologies

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Gap analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTLE analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Instruments

5.3&nbsp;&nbsp;&nbsp; Kits and consumables

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Imaging

6.2.1&nbsp;&nbsp;&nbsp; Mammography

6.2.2&nbsp;&nbsp;&nbsp; MRI

6.2.3&nbsp;&nbsp;&nbsp; Ultrasound

6.2.4&nbsp;&nbsp;&nbsp; PET/CT

6.3&nbsp;&nbsp;&nbsp; Biopsy

6.4&nbsp;&nbsp;&nbsp; Genomic tests

6.5&nbsp;&nbsp;&nbsp; Blood tests

6.6&nbsp;&nbsp;&nbsp; Other test types

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cancer Type, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Ductal carcinoma in situ

7.3&nbsp;&nbsp;&nbsp; Invasive ductal carcinoma

7.4&nbsp;&nbsp;&nbsp; Inflammatory breast cancer

7.5&nbsp;&nbsp;&nbsp; Metastatic breast cancer

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Screening

8.3&nbsp;&nbsp;&nbsp; Diagnostic and predictive

8.4&nbsp;&nbsp;&nbsp; Prognostic

8.5&nbsp;&nbsp;&nbsp; Research

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

9.3&nbsp;&nbsp;&nbsp; Diagnostic centers

9.4&nbsp;&nbsp;&nbsp; Cancer research institutes

9.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Spain

10.3.5&nbsp;&nbsp;&nbsp;Italy

10.3.6&nbsp;&nbsp;&nbsp;Netherlands

10.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;China

10.4.2&nbsp;&nbsp;&nbsp;Japan

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Argentina

10.5.4&nbsp;&nbsp;&nbsp;Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;South Africa

10.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp;UAE

10.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Argon Medical Devices

11.2&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

11.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

11.4&nbsp;&nbsp;&nbsp; Canon Inc.

11.5&nbsp;&nbsp;&nbsp; Danaher Corporation

11.6&nbsp;&nbsp;&nbsp; Exact Sciences Corporation

11.7&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

11.8&nbsp;&nbsp;&nbsp; FUJIFILM Holdings Corporation

11.9&nbsp;&nbsp;&nbsp; Hologic, Inc.

11.10&nbsp;&nbsp;&nbsp; Illumina, Inc.

11.11&nbsp;&nbsp;&nbsp; Koninklijke Philips N.V.

11.12&nbsp;&nbsp;&nbsp; Myriad Genetics, Inc.

11.13&nbsp;&nbsp;&nbsp; QIAGEN N.V.

11.14&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

11.15&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. 
&nbsp;

Breast Cancer Diagnostics Market

Get a free sample of this report